AGP Picks
View all

Healthy Living Arizona: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.

Press releases published on August 14, 2026

KPG Healthcare Partners with Staffing Referrals to Launch Enhanced Healthcare Referral Program
ACMT Position Statement: Public Health Concerns Associated with 7-Hydroxymitragynine and Other Kratom Compounds
Global Water-Soluble Films Market to Reach $798.8 Million by 2031, Driven by Plastic Ban Regulations and Rising Demand for Sustainable Packaging
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth
Vaso Corporation Announces Financial Results for Second Quarter of 2026
NurExone Reports New Preclinical Tissue-Analysis Data Supporting Potential Neuroprotective Effect of ExoPTEN in Acute Spinal Cord Injury Animal Model
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
NOMAD POWER SOLUTIONS FILES 2026 SECOND QUARTER FORM 10-Q, PROVIDES BUSINESS UPDATE
Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update
BiomX Subsidiary Zorronet Receives Approximately $300,000 Purchase Order to Build Unified Operational Environment at Defense Technology Test and Evaluation Site
Sienna Announces August Dividend
Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
TOMI Environmental Solutions, Inc. Reports Second Quarter 2026 Financial Results
SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance
Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Arizona

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.